Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma

Fudan University · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
chemotherapyimmune-checkpoint-inhibitornasopharyngeal-carcinoma
nasopharyngeal carcinoma, primary metastatic, de novo metastatic, toripalimab, pd-1, immune checkpoint inhibitor, chemotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 860409
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.